Post-treatment haemolysis is common following oral artemisinin combination therapy of uncomplicated malaria in travellers
Autor: | Florian Kurth, Pinkus Tober-Lau, Tilman Lingscheid, Lara Bardtke, Johanna Kim, Andrea Angheben, Federico G Gobbi, Lena Mbavu, Miriam S Stegemann, Katrin M Heim, Frieder Pfäfflin, Nikolai Menner, Mariana Schürmann, Agata Mikolajewska, Martin Witzenrath, Leif E Sander, Beate Mayer, Thomas Zoller |
---|---|
Rok vydání: | 2023 |
Předmět: | |
Zdroj: | Journal of Travel Medicine. 30 |
ISSN: | 1708-8305 1195-1982 |
Popis: | Background Artemisinin-based combination therapy (ACT) for the treatment of malaria is highly effective, well tolerated and safe. Episodes of delayed haemolysis occur in up to 57.9% of patients with severe malaria treated with intravenous artesunate, mainly caused by ‘pitting’ of infected red blood cells in the spleen and the delayed loss of these once-infected RBCs (oiRBCs). Several reports indicate that post-treatment haemolysis (PTH) also occurs in uncomplicated malaria treated with oral ACT, calling for systematic investigation. Methods A prospective observational study to identify the incidence of PTH after oral ACT, defined as increased lactate dehydrogenase activity and low haptoglobin level on Day 14 after treatment. Patients were enrolled at two study centres in Germany and Italy. Study visits took place on Days 1, 3, 7, 14 and 28. Laboratory investigations included extended clinical routine laboratory tests, quantitative PfHRP2, anti-RBC antibodies and oiRBCs. The state of semi-immunity to malaria was assessed from childhood and ongoing exposure to Plasmodium spp. as per patient history. Results A total of 134 patients with uncomplicated malaria and 3-day ACT treatment were recruited. Thirty-seven (37.4%) of 99 evaluable patients with Pf and none of 9 patients with non-Pf malaria exhibited PTH on d14. Patients with PTH had higher initial parasitaemia, higher oiRBC counts on d3 and a 10-fold decrease in oiRBCs between d7 and d14 compared with patients without PTH. In patients with PTH, loss of haemoglobin was 4-fold greater in non-Africans than in Africans (−1.3 vs −0.3 g/dl). Semi-immune African patients with PTH showed markedly increased erythropoiesis on d14 compared with not semi-immune African and non-African patients with PTH. Conclusions PTH is common in patients with uncomplicated malaria and oral ACT. While the observed loss of haemoglobin will often not be clinically relevant, it could aggravate pre-existing anaemia, warranting follow-up examinations in populations at risk. |
Databáze: | OpenAIRE |
Externí odkaz: |